292 related articles for article (PubMed ID: 30677801)
1. Unusual eruption in association with sorafenib: a case of acquired perforating dermatosis, reactive perforating collagenosis type.
Lederhandler M; Beasley JM; Brinster NK; Nagler AR
Dermatol Online J; 2018 Dec; 24(12):. PubMed ID: 30677801
[TBL] [Abstract][Full Text] [Related]
2. Reactive perforating collagenosis: a rare side effect associated with sorafenib.
Vega Díez D; Gómez Zubiaur A; Medina Montalvo S
Rev Esp Enferm Dig; 2020 Dec; 112(12):960-961. PubMed ID: 33226256
[TBL] [Abstract][Full Text] [Related]
3. [Acquired perforating dermatosis in the patient with chronic kidney disease – case report and literature review].
Steć A; Paluch-Oleś J; Korolczuk A; Magdalena Grzebalska A; Kozioł-Montewka M; Książek A
Przegl Lek; 2016; 73(9):680-3. PubMed ID: 29688682
[TBL] [Abstract][Full Text] [Related]
4. Acquired perforating dermatosis in a patient with chronic renal failure.
Fernandes KA; Lima LA; Guedes JC; Lima RB; D'Acri AM; Martins CJ
An Bras Dermatol; 2016; 91(5 suppl 1):10-13. PubMed ID: 28300880
[TBL] [Abstract][Full Text] [Related]
5. Acquired reactive perforating collagenosis in association with prostate adenocarcinoma, chronic lymphocytic leukemia, and Graves' disease.
Huseynova L; Akdogan N; Gököz Ö; Evans SE
An Bras Dermatol; 2020; 95(3):336-339. PubMed ID: 32359703
[TBL] [Abstract][Full Text] [Related]
6. Acquired reactive perforating collagenosis in a diabetic patient with pulmonary aspergillosis.
Kim JH; Kang WH
Cutis; 2000 Dec; 66(6):425-30. PubMed ID: 11138360
[TBL] [Abstract][Full Text] [Related]
7. Reactive perforating collagenosis and acquired perforating dermatosis: presentation of two cases.
Kyriaki A; Ephtichia Z; Anna L; Panagiotis D
J Dermatol; 1997 Mar; 24(3):170-3. PubMed ID: 9114614
[TBL] [Abstract][Full Text] [Related]
8. [Acquired reactive perforating collagenosis: report of two cases].
Cárdenas D C; Bello C C; Uribe G P; Romero G W; González B S
Rev Med Chil; 2010 Oct; 138(10):1281-4. PubMed ID: 21279276
[TBL] [Abstract][Full Text] [Related]
9. Acquired reactive perforating collagenosis: four patients with a giant variant treated with allopurinol.
Hoque SR; Ameen M; Holden CA
Br J Dermatol; 2006 Apr; 154(4):759-62. PubMed ID: 16536825
[TBL] [Abstract][Full Text] [Related]
10. Expression of the 67-kDa elastin receptor in perforating skin disorders.
Fujimoto N; Akagi A; Tajima S; Ishibashi A; Nomura K; Matsushita A; Nagai Y; Shishiba K
Br J Dermatol; 2002 Jan; 146(1):74-9. PubMed ID: 11841369
[TBL] [Abstract][Full Text] [Related]
11. Acquired perforating dermatosis: clinicopathological features in twenty-two cases.
Saray Y; Seçkin D; Bilezikçi B
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):679-88. PubMed ID: 16836495
[TBL] [Abstract][Full Text] [Related]
12. Acquired reactive perforating collagenosis: current status.
Karpouzis A; Giatromanolaki A; Sivridis E; Kouskoukis C
J Dermatol; 2010 Jul; 37(7):585-92. PubMed ID: 20629824
[TBL] [Abstract][Full Text] [Related]
13. Reactive Perforating Collagenosis.
Kanitakis J
Skinmed; 2018; 16(6):390-396. PubMed ID: 30575506
[TBL] [Abstract][Full Text] [Related]
14. Erlotinib-induced reactive perforating collagenosis in a case of lung adenocarcinoma.
Jiang X; Song TT; Hao F
Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):548-551. PubMed ID: 34219432
[No Abstract] [Full Text] [Related]
15. Characteristics of acquired reactive perforating collagenosis.
Tsuboi H; Katsuoka K
J Dermatol; 2007 Sep; 34(9):640-4. PubMed ID: 17727367
[TBL] [Abstract][Full Text] [Related]
16. Acquired reactive perforating collagenosis induced by indinavir in 2 patients with HIV disease.
Calista D; Morri M
Eur J Dermatol; 2008; 18(1):84-5. PubMed ID: 18086600
[No Abstract] [Full Text] [Related]
17. Perforating dermatosis associated with multikinase inhibitors: report of two cases, including one associated with lenvatinib.
Sato-Sano M; Cury-Martins J; Macarenco R; Domingues RB; Vasconcelos R; Sanches JA
J Dtsch Dermatol Ges; 2018 Dec; 16(12):1486-1489. PubMed ID: 30466160
[No Abstract] [Full Text] [Related]
18. Acquired reactive perforating collagenosis, a rare entity at uncommon site.
Ambalathinkal JJ; Phiske MM; Someshwar SJ
Indian J Pathol Microbiol; 2022; 65(4):895-897. PubMed ID: 36308201
[TBL] [Abstract][Full Text] [Related]
19. Acquired reactive perforating collagenosis.
Basak PY; Turkmen C
Eur J Dermatol; 2001; 11(5):466-8. PubMed ID: 11525959
[TBL] [Abstract][Full Text] [Related]
20. Acquired Reactive Perforating Collagenosis Occurring in Association With Nonred Ink Tattoo.
Grube VL; Safeer LZ; Hafeez F
Am J Dermatopathol; 2022 Aug; 44(8):581-583. PubMed ID: 35234188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
